Sanjeev Chunilal
Overview
Explore the profile of Sanjeev Chunilal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stevens H, McFadyen J, Mellett N, Lynn D, Duong T, Giles C, et al.
Res Pract Thromb Haemost
. 2025 Mar;
9(1):102677.
PMID: 40041449
Background: VITT has emerged as a rare but serious adverse event linked primarily to adenoviral vector COVID-19 vaccinations, such as ChAdOx1-S (Oxford/AstraZeneca) vaccination. The syndrome is characterized by thrombosis with...
2.
Tran H, Dix C, Bird R, Chunilal S, Brighton T, Reynolds J, et al.
Am J Hematol
. 2024 Dec;
100(3):516-519.
PMID: 39715073
No abstract available.
3.
Tedjaseputra A, Roy S, Htun K, Oh D, McQuilten Z, Yeh P, et al.
Pathology
. 2024 Apr;
56(4):548-555.
PMID: 38580614
Early induction response assessment with day-21 bone marrow (D21-BM) is commonly performed in patients with FLT3-mutated acute myeloid leukaemia (AML), where detection of residual leukaemia (RL; blasts ≥5%) typically results...
4.
Keragala C, McFadyen J, Ho H, McCutcheon F, Liu Z, Stevens H, et al.
J Thromb Haemost
. 2023 Nov;
22(3):785-793.
PMID: 37944898
Background: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare complication of adenovirus vector-based COVID-19 vaccines. VITT is associated with markedly raised levels of D-dimer; yet, how VITT modulates the fibrinolytic...
5.
Edwards E, Ojaimi S, Ngui J, Seo G, Kim J, Chunilal S, et al.
J Allergy Clin Immunol
. 2023 May;
152(3):807-813.e7.
PMID: 37211057
Background: Inborn errors affecting components of the T-cell receptor signaling cascade cause combined immunodeficiency with various degrees of severity. Recently, homozygous variants in LCP2 were reported to cause pediatric onset...
6.
Lee C, Clarke L, Kershaw G, Tohidi-Esfahani I, Brighton T, Chunilal S, et al.
Res Pract Thromb Haemost
. 2023 May;
7(3):100128.
PMID: 37122532
Background: Anti-platelet factor 4 (PF4) antibodies in vaccine-induced immune thrombotic thrombocytopenia (VITT) appear to be transient, with discrepant persistence depending on the platform used for detection. Objectives: We aimed to...
7.
Yuen H, Weinkove R, Ullman A, Marsh N, Rickard C, Chunilal S, et al.
Intern Med J
. 2023 Mar;
53(3):426-430.
PMID: 36920141
Central venous access devices (CVADs) are commonly used in malignancies. We conducted an online, anonymous cross-sectional survey of practice regarding CVAD management in haematology centres among clinicians in Australia and...
8.
Favaloro E, Clifford J, Leitinger E, Parker M, Sung P, Chunilal S, et al.
J Thromb Haemost
. 2022 Sep;
20(12):2896-2908.
PMID: 36107495
Background: Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare complication of adenovirus-based vaccines aimed to prevent and minimize COVID-19 and related pathophysiology. Objectives: To describe patterns of testing for anti-platelet factor...
9.
Dix C, McFadyen J, Huang A, Chunilal S, Chen V, Tran H
Intern Med J
. 2022 Apr;
52(5):717-723.
PMID: 35446471
Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare, but serious, syndrome characterised by thrombocytopenia, thrombosis, a markedly raised D-dimer and the presence of anti-platelet factor-4 (PF4) antibodies following COVID-19 adenovirus vector...
10.
Day T, Tran H, Chunilal S, Bortz H, Esterman A
Injury
. 2022 Feb;
53(7):2562-2566.
PMID: 35197204
Background: Isolated distal deep vein thromboses (IDDVT) are common complications of trauma inpatient admission, however their management is controversial. We aimed to analyse outcomes in patients admitted to a level...